NASDAQ:AGRX - Agile Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.34 -0.02 (-5.56 %)
(As of 09/21/2018 04:00 PM ET)
Previous Close$0.35
Today's Range$0.34 - $0.36
52-Week Range$0.23 - $5.40
Volume690,127 shs
Average Volume849,726 shs
Market Capitalization$11.55 million
P/E Ratio-0.38
Dividend YieldN/A
Beta1.47

Headlines

Agile Therapeutics (NASDAQ AGRX) News Headlines

Source:
DateHeadline
Agile Therapeutics Inc (AGRX) Expected to Post Earnings of -$0.17 Per ShareAgile Therapeutics Inc (AGRX) Expected to Post Earnings of -$0.17 Per Share
www.americanbankingnews.com - September 19 at 4:24 AM
AGRX Sep 2018 7.500 callAGRX Sep 2018 7.500 call
finance.yahoo.com - September 18 at 4:59 PM
Agile Therapeutics Inc (AGRX) Given Average Rating of "Buy" by AnalystsAgile Therapeutics Inc (AGRX) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - September 16 at 11:06 AM
Does Agile Therapeutics Inc (NASDAQ:AGRX) Fall With The Market?Does Agile Therapeutics Inc (NASDAQ:AGRX) Fall With The Market?
finance.yahoo.com - September 14 at 5:00 PM
Agile Therapeutics up 55% premarketAgile Therapeutics up 55% premarket
seekingalpha.com - September 11 at 4:55 PM
Consolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance IndicationsConsolidated Research: 2018 Summary Expectations for Internap, Approach Resources, Agile Therapeutics, Town Sports International, Dicerna Pharmaceuticals, and Cott — Fundamental Analysis, Key Performance Indications
finance.yahoo.com - August 29 at 8:27 AM
AGRX: Formal Dispute Resolution Continues to Office of New Drugs…AGRX: Formal Dispute Resolution Continues to Office of New Drugs…
finance.yahoo.com - August 9 at 6:03 PM
Agile Therapeutics Reports Second Quarter 2018 Financial ResultsAgile Therapeutics Reports Second Quarter 2018 Financial Results
finance.yahoo.com - August 3 at 8:23 AM
Agile Therapeutics: 2Q Earnings SnapshotAgile Therapeutics: 2Q Earnings Snapshot
finance.yahoo.com - August 3 at 8:23 AM
Complimentary Technical Snapshots on Akorn and Three More Generic Drugs StocksComplimentary Technical Snapshots on Akorn and Three More Generic Drugs Stocks
finance.yahoo.com - July 31 at 8:29 AM
Pre-Open Movers 07/25: (TORC) (NVRO) (IRBT) Higher; (AGRX) (AOBC) (FCAU) Lower (more...)Pre-Open Movers 07/25: (TORC) (NVRO) (IRBT) Higher; (AGRX) (AOBC) (FCAU) Lower (more...)
www.streetinsider.com - July 26 at 8:17 AM
Mid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares PlungeMid-Day Market Update: Crude Oil Up Over 1%; Agile Therapeutics Shares Plunge
www.nasdaq.com - July 26 at 8:17 AM
FDA rejects Agiles appeal of Twirla CRL; shares down 41% after hoursFDA rejects Agile's appeal of Twirla CRL; shares down 41% after hours
seekingalpha.com - July 25 at 8:19 AM
FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution RequestFDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request
finance.yahoo.com - July 24 at 4:47 PM
Form 8-K AGILE THERAPEUTICS INC For: Jul 02Form 8-K AGILE THERAPEUTICS INC For: Jul 02
www.streetinsider.com - July 10 at 4:58 PM
Benzingas Daily Biotech Pulse: Titans Parkinsons Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% PremiumBenzinga's Daily Biotech Pulse: Titan's Parkinson's Disease Drug Implant Trial, Juniper Pharma Sells Itself At 32% Premium
www.msn.com - July 3 at 8:49 AM
Free Technical Research on Akorn and Three More Generic Drugs EquitiesFree Technical Research on Akorn and Three More Generic Drugs Equities
finance.yahoo.com - June 25 at 8:39 AM
AGRX: Files Formal Dispute Resolution with the FDAAGRX: Files Formal Dispute Resolution with the FDA
finance.yahoo.com - June 8 at 5:31 PM
Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash GuidanceAgile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance
finance.yahoo.com - June 7 at 5:25 PM
AGRX: Determining a Path Forward Following Receipt of Meeting MinutesAGRX: Determining a Path Forward Following Receipt of Meeting Minutes
finance.yahoo.com - May 22 at 5:09 PM
Agile Therapeutics Is Attempting A Hail Mary Play With A Formal Dispute ResolutionAgile Therapeutics Is Attempting A Hail Mary Play With A Formal Dispute Resolution
seekingalpha.com - May 21 at 5:10 PM
Today’s Research Reports on Stocks to Watch: Agile Therapeutics and Arrowhead PharmaceuticalsToday’s Research Reports on Stocks to Watch: Agile Therapeutics and Arrowhead Pharmaceuticals
finance.yahoo.com - May 21 at 8:15 AM
Agile Therapeutics (AGRX) Announces Regulatory Update on Twirla; FDA Continues to have Significant ConcernsAgile Therapeutics (AGRX) Announces Regulatory Update on Twirla; FDA Continues to have Significant Concerns
www.streetinsider.com - May 18 at 6:01 PM
Agile Therapeutics down 76% on additional work needed for U.S. approval of TwirlaAgile Therapeutics down 76% on additional work needed for U.S. approval of Twirla
seekingalpha.com - May 18 at 6:01 PM
Agile Therapeutics sinks after FDA feedback on contraceptiveAgile Therapeutics sinks after FDA feedback on contraceptive
finance.yahoo.com - May 18 at 6:01 PM
Consolidated Research: 2018 Summary Expectations for Verint, Mesabi Trust, Clearwater Paper, AgileConsolidated Research: 2018 Summary Expectations for Verint, Mesabi Trust, Clearwater Paper, Agile
www.nasdaq.com - May 18 at 8:39 AM
Agile Therapeutics, Inc. Provides Regulatory Update on Twirla® (AG200-15) for the Prevention of PregnancyAgile Therapeutics, Inc. Provides Regulatory Update on Twirla® (AG200-15) for the Prevention of Pregnancy
finance.yahoo.com - May 18 at 8:39 AM
Agile Therapeutics (AGRX) Provides Twirla Update; Says FDA Has Significant Concerns Regarding the Adhesion of TwirlaAgile Therapeutics (AGRX) Provides Twirla Update; Says FDA Has Significant Concerns Regarding the Adhesion of Twirla
www.streetinsider.com - May 18 at 8:39 AM
AGRX: Waiting on Meeting Minutes from FDA; Planning for 2Q18 Twirla® NDA ResubmissionAGRX: Waiting on Meeting Minutes from FDA; Planning for 2Q18 Twirla® NDA Resubmission
finance.yahoo.com - May 14 at 5:21 PM
Have Investors Priced In Agile Therapeutics Inc’s (NASDAQ:AGRX) Growth?Have Investors Priced In Agile Therapeutics Inc’s (NASDAQ:AGRX) Growth?
finance.yahoo.com - May 12 at 8:24 AM
Agile Therapeutics Reports First Quarter 2018 Financial ResultsAgile Therapeutics Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 7 at 5:38 PM
Agile Therapeutics: 1Q Earnings SnapshotAgile Therapeutics: 1Q Earnings Snapshot
finance.yahoo.com - May 7 at 5:38 PM
When Can We Expect A Profit From Agile Therapeutics Inc (NASDAQ:AGRX)?When Can We Expect A Profit From Agile Therapeutics Inc (NASDAQ:AGRX)?
finance.yahoo.com - May 3 at 8:16 AM
What Should Investors Know About Agile Therapeutics Inc’s (NASDAQ:AGRX) Long Term Outlook?What Should Investors Know About Agile Therapeutics Inc’s (NASDAQ:AGRX) Long Term Outlook?
finance.yahoo.com - March 28 at 5:19 PM
Pre-Market Technical Scan on Generic Drugs Equities -- Adamas Pharma, Agile Therapeutics, Catalent, and Diplomat PharmacyPre-Market Technical Scan on Generic Drugs Equities -- Adamas Pharma, Agile Therapeutics, Catalent, and Diplomat Pharmacy
www.prnewswire.com - March 26 at 8:22 AM
New Research: Key Drivers of Growth for At Home Group, Griffon, Mitek, J & J Snack Foods, Lindsay, and Agile Therapeutics — Factors of Influence, Major Initiatives and Sustained ProductionNew Research: Key Drivers of Growth for At Home Group, Griffon, Mitek, J & J Snack Foods, Lindsay, and Agile Therapeutics — Factors of Influence, Major Initiatives and Sustained Production
finance.yahoo.com - March 23 at 8:18 AM
Is Agile Therapeutics Inc’s (NASDAQ:AGRX) Balance Sheet A Threat To Its Future?Is Agile Therapeutics Inc’s (NASDAQ:AGRX) Balance Sheet A Threat To Its Future?
finance.yahoo.com - March 20 at 5:18 PM
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition - GlobeNewswire (press release)Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition - GlobeNewswire (press release)
globenewswire.com - March 14 at 8:31 AM
Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & ExpositionAbstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
finance.yahoo.com - March 14 at 8:31 AM
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 ... - NasdaqAgile Therapeutics Reports Fourth Quarter and Full Year 2017 ... - Nasdaq
www.nasdaq.com - March 13 at 8:25 AM
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results - GlobeNewswire (press release)Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - March 13 at 8:25 AM
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial ResultsAgile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 12 at 6:40 PM
New Research Coverage Highlights Oracle, General Dynamics, Agile Therapeutics, Fidelity Southern, Syros Pharmaceuticals, and MSA Safety Incorporated — Consolidated Revenues, Company Growth, and Expectations for 2018New Research Coverage Highlights Oracle, General Dynamics, Agile Therapeutics, Fidelity Southern, Syros Pharmaceuticals, and MSA Safety Incorporated — Consolidated Revenues, Company Growth, and Expectations for 2018
finance.yahoo.com - January 24 at 8:06 AM
Technical Perspectives on Generic Drugs Stocks -- Fibrocell Science, Galectin Therapeutics, Agile Therapeutics, and ... - PR Newswire (press release)Technical Perspectives on Generic Drugs Stocks -- Fibrocell Science, Galectin Therapeutics, Agile Therapeutics, and ... - PR Newswire (press release)
www.prnewswire.com - January 20 at 7:25 AM
Agile Therapeutics: Sell-Off Post CRL Makes It Worth A Look - Seeking AlphaAgile Therapeutics: Sell-Off Post CRL Makes It Worth A Look - Seeking Alpha
seekingalpha.com - December 27 at 9:58 AM
Agile Therapeutics plunges toward record low after FDA rejects contraceptive patchs NDA - MarketWatchAgile Therapeutics plunges toward record low after FDA rejects contraceptive patch's NDA - MarketWatch
www.marketwatch.com - December 23 at 3:46 PM
Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention ... - GlobeNewswire (press release)Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention ... - GlobeNewswire (press release)
globenewswire.com - December 23 at 3:46 PM
Agile Therapeutics (AGRX) Receives CRL from FDA for Twirla for Prevention of PregnancyAgile Therapeutics (AGRX) Receives CRL from FDA for Twirla for Prevention of Pregnancy
www.streetinsider.com - December 22 at 8:42 PM
Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention of PregnancyAgile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention of Pregnancy
finance.yahoo.com - December 22 at 8:42 PM
Agile Therapeutics plunges toward record low after FDA rejects contraceptive patchs NDAAgile Therapeutics plunges toward record low after FDA rejects contraceptive patch's NDA
finance.yahoo.com - December 22 at 8:42 PM
This page was last updated on 9/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel